Using salt to drive drug-carrying particles deeper into difficult-to-treat biofilms

Researchers at Yale University have discovered a novel method to enhance the delivery of drug-carrying particles into biofilms, a complex network of bacterial colonies encased in a sticky, polymer-like matrix. These biofilms are notoriously resistant to conventional antibiotic treatments due to their structure, which hinders the penetration of therapeutic agents. By introducing a controlled salt gradient, the team has demonstrated a technique that drives particles deeper into the biofilm, potentially improving treatment efficacy against persistent infections. In a study published in Soft Matter, the researchers used a microfluidic system to simulate biofilm environments and test the effectiveness of their approach. They created biofilms using E. coli and exposed them to varying concentrations of salt solutions. When colloidal particles were introduced into a low-salt environment adjacent to a high-salt region within the biofilm, the salt gradient induced a phenomenon called diffusiophoresis. This process caused the particles to move toward the high-salt area, effectively penetrating deeper into the biofilm than previously possible. Professor Amir Pahlavan, who led the research, explained that traditional methods of drug delivery rely on passive diffusion, which is often inefficient and requires high doses of particles to achieve adequate penetration. "Diffusion of nano- and micron-sized particles can be very slow and inefficient," Pahlavan said. "That can require a large dose of particles, so that some of them reach the target." The study revealed that the effectiveness of the salt-driven delivery method depended heavily on the maturity of the biofilm. In younger, less dense biofilms, the particles achieved significantly greater penetration compared to control experiments without a salt gradient. However, as the biofilm aged and became denser, the penetration depth decreased until it reached levels similar to those observed in the absence of a salt gradient. Interestingly, the research also uncovered an unexpected finding regarding particle size. Larger particles, measuring 1,000 nanometers, were able to penetrate further into the biofilm compared to smaller 40-nanometer particles. This contradicted initial assumptions that smaller particles would navigate tighter spaces more effectively. First author Zehao Chen, a doctoral student conducting the experiments, noted that the larger particles exhibited a stronger response to the salt gradient under the tested conditions. This suggests that the optimal particle size for drug delivery may vary depending on the specific characteristics of the biofilm. The researchers hypothesize that the salt-induced movement of particles could cause physical deformation of the biofilm matrix, potentially facilitating the removal of biofilms over time. However, whether this process can consistently break down biofilms remains to be determined through further experimentation. Pahlavan emphasized that the study highlights how biofilm density can be leveraged as a design parameter rather than merely viewed as an obstacle. "It identifies the window in which gradient-driven delivery works and the denser regime in which that advantage is largely lost," he said. The findings suggest that the principles underlying this technique could extend beyond biomedical applications to areas such as water treatment and industrial processes, where biofilms often clog equipment and infrastructure. The research opens new avenues for developing targeted therapies against biofilm-associated infections, particularly in clinical settings involving medical implants and devices. By optimizing particle size and salt gradients, future studies may refine this approach to improve its reliability and effectiveness in treating biofilm-related diseases. The team plans to investigate the underlying physics governing the interaction between salt gradients and biofilm structures, aiming to uncover mechanisms that could be applied to broader contexts.